drugset / Trial / NCT06435182
Study of OT202 in Treating Moderate to Severe Dry Eye
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a phase II study to explore the optimal dosage of OT202 in treating dry eye.
Timeline
- Start
- 2023-04-10
- Primary completion
- 2024-01-26
- Completion
- 2024-01-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OT202 | Unknown | 0.1 % | Other |
| Subject | OT202 | Unknown | 0.5 % | Other |